X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Iceland Pharmaceutical Companies (2024 - 2029)

Several prominent companies in the pharmaceutical industry are making significant strides in various areas of healthcare. These corporations are engaging in research, development, and distribution of innovative treatments and therapies. These businesses are demonstrating their commitment to improving global health by investing in new technologies and pioneering research. Their efforts highlight the crucial role of such enterprises in the healthcare sector.

Home Market Analysis Healthcare Research Pharmaceuticals Research Iceland Pharma Market Companies

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Top Companies in Iceland Pharmaceutical Market

This report lists the top Iceland Pharmaceutical companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Iceland Pharmaceutical industry.

  1. Alvogen

  2. Johnson & Johnson

  3. Novartis

  4. Pfizer

  5. Sanofi

*Disclaimer: Top companies sorted in no particular order

Iceland Pharmaceutical Market Major Players

Iceland Pharmaceutical Market Concentration

Iceland Pharmaceutical Market Concentration

Iceland Pharmaceutical Company List

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions & Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

      1. 4.1.1 Healthcare Expenditure (Govt. Vs Private)

      2. 4.1.2 Pharmaceutical Imports and Exports

      3. 4.1.3 Epidemeology Data For key Diseases

      4. 4.1.4 Regulatory Landscape/Regulatory Bodies

      5. 4.1.5 Licensing and Market Authorization (For both Local Production and Imported Goods)

      6. 4.1.6 Pipeline Analysis

        1. 4.1.6.1 By Phase

        2. 4.1.6.2 By Sponsor

        3. 4.1.6.3 By Disease

      7. 4.1.7 Statiscal Overview

        1. 4.1.7.1 Number of Hospitals

        2. 4.1.7.2 Employment in the Pharmaceutical Sector

        3. 4.1.7.3 R&D Expenditure

      8. 4.1.8 Ease of Doing Business

    2. 4.2 Market Drivers

      1. 4.2.1 Rising cases of Chronic Diseases and Government Supportive Initiatives

      2. 4.2.2 International Partnership

    3. 4.3 Market Restraints

      1. 4.3.1 Shortage of Medicines

      2. 4.3.2 Side Effects Associated with Medicines

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By ATC/Therapeutic Class (Value)

      1. 5.1.1 Alimentary tract and metabolisma

      2. 5.1.2 Blood and blood forming organs

      3. 5.1.3 Cardiovascular system

      4. 5.1.4 Dermatological drugs

      5. 5.1.5 Genitourinary system and reproductive hormones

      6. 5.1.6 Systemic hormonal preparations, excluding reproductive hormones and insulins

      7. 5.1.7 Antiinfectives for systemic use

      8. 5.1.8 Antineoplastic and immunomodulating agents

      9. 5.1.9 Musculoskeletal system

      10. 5.1.10 Nervous system

      11. 5.1.11 Antiparasitic products, insecticides and repellents

      12. 5.1.12 Respiratory system

      13. 5.1.13 Sensory organs

      14. 5.1.14 Various ATC structures

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Alvogen

      2. 6.1.2 GlaxoSmithKline Plc

      3. 6.1.3 Amgen

      4. 6.1.4 EpiEndo Pharmaceuticals ehf

      5. 6.1.5 Johnson & Johnson

      6. 6.1.6 Merck & Co., Inc.,

      7. 6.1.7 Novartis AG

      8. 6.1.8 Pfizer Inc

      9. 6.1.9 Sanofi SA

    2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS


Specific to Iceland Pharmaceutical Market
Need More Details On Market Players And Competitors?
Download PDF

Competitive Landscape Report Includes

Company Profiles (includes Global Level Overview, Market Level Overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and Analysis of Recent Developments). Key Strategic Moves, Market Share Analysis, Company Landscape, and List of Companies.

Iceland Pharmaceutical Market Companies Summary

The pharmaceutical industry in Iceland has been impacted by the COVID-19 pandemic, with supply chains and procurement of essential medical supplies under significant pressure. The demand for certain pharmaceuticals used in the treatment of various disorders has increased, further straining the market. However, market growth is also being driven by an aging population more susceptible to chronic diseases, increasing the demand for pharmaceutical drugs. This, coupled with international partnerships, is contributing to the expansion of the industry. Several enterprises in the Iceland market have been increasing their research and development and manufacturing expenditures over the past few years. This increased investment is expected to support the overall growth of the Icelandic pharmaceutical industry. Despite this, the market's growth is being hindered by a shortage of certain medications. However, regulatory bodies are taking steps to mitigate these occurrences. Additionally, the approval of new products in the country is contributing to market expansion. The market is also benefiting from innovative medications, the existence of a strong pipeline, and government policies that increase disease awareness.

Explore More

Iceland Pharmaceutical Companies - Table of Contents

  1. 1. COMPETITIVE LANDSCAPE

    1. 1.1 Company Profiles

      1. 1.1.1 Alvogen

      2. 1.1.2 GlaxoSmithKline Plc

      3. 1.1.3 Amgen

      4. 1.1.4 EpiEndo Pharmaceuticals ehf

      5. 1.1.5 Johnson & Johnson

      6. 1.1.6 Merck & Co., Inc.,

      7. 1.1.7 Novartis AG

      8. 1.1.8 Pfizer Inc

      9. 1.1.9 Sanofi SA

    2. *List Not Exhaustive

Iceland Pharmaceutical Companies FAQs

Alvogen, Johnson & Johnson, Novartis AG, Pfizer Inc and Sanofi SA are the major companies operating in the Iceland Pharmaceutical Market.

Iceland Pharmaceutical Market Report Snapshots

Iceland Pharmaceutical Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)